OK2

OK2, a specific inhibitor of the CCN2/EGFR interaction, efficiently blocks CCN2/EGFR interaction through binding to the CT domain of CCN2. OK2 can be used for kidney fibrosis and chronic kidney disease research[1].

C42H62N14O9

907.03

O[C@H](C)[C@@H](C(N1)=O)NC([C@H](CC2=CNC3=CC=CC=C32)NC([C@@H]4CCCN4C([C@H](CCCNC(N)=N)NC([C@H](CC5=CNC=N5)NC([C@H](CCCCN)NC([C@@H]1[C@H](O)C)=O)=O)=O)=O)=O)=O

EGFR; STAT

STAT3

99.13

DMSO : 100 mg/mL (ultrasonic)

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

Blue Ice